Yul Hwangbo Selected Research

Yul Hwangbo Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 03/2017
8	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 01/2018
5	Type 2 Diabetes Mellitus (MODY) 10/2022 - 04/2012
3	Insulin Resistance 09/2021 - 03/2017
3	Hypertension (High Blood Pressure) 01/2021 - 01/2019
2	Papillary Thyroid Cancer 10/2021 - 01/2020
2	Obesity 01/2021 - 01/2021
2	Hypothyroidism 10/2020 - 01/2018
2	Thyroid Diseases (Thyroid Disease) 10/2018 - 06/2018
1	Stroke (Strokes) 10/2022
1	Stomach Neoplasms (Stomach Cancer) 09/2021
1	Diabetes Mellitus 04/2021
1	Colorectal Neoplasms (Colorectal Cancer) 04/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2021
1	Lymphatic Metastasis 01/2020
1	Sepsis (Septicemia) 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2018
1	Hyperglycemia 03/2017
1	Hematologic Neoplasms (Hematological Malignancy) 03/2017
1	Weight Gain 07/2015
1	Hypoglycemia (Reactive Hypoglycemia) 07/2015
1	Latent Autoimmune Diabetes in Adults 04/2012

Drug/Important Bio-Agent (IBA)

6	ORALIT (ORS)IBA 01/2022 - 01/2020
4	IodineIBA 01/2022 - 07/2019
2	Metformin (Glucophage)FDA LinkGeneric 10/2022 - 07/2015
2	Glucose (Dextrose)FDA LinkGeneric 05/2018 - 03/2017
2	Insulin (Novolin)FDA Link 05/2018 - 03/2017
1	SymportersIBA 01/2022
1	SodiumIBA 01/2022
1	ResistinIBA 09/2021
1	LeptinIBA 09/2021
1	Plasminogen Activators (Plasminogen Activator)IBA 09/2021
1	SteroidsIBA 04/2021
1	Indicators and Reagents (Reagents)IBA 02/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 07/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	ThiazidesIBA 01/2019
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	Thyroid HormonesIBA 10/2018
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 06/2018
1	Non-Receptor Type 22 Protein Tyrosine PhosphataseIBA 06/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 06/2018
1	Neuregulin-1 (Neuregulin 1)IBA 06/2018
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 06/2018
1	Proteins (Proteins, Gene)FDA Link 06/2018
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2018
1	C-PeptideIBA 05/2018
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2018
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018
1	MTOR InhibitorsIBA 03/2017
1	Immune Checkpoint InhibitorsIBA 03/2017
1	TOR Serine-Threonine KinasesIBA 03/2017
1	Asparaginase (Elspar)FDA Link 03/2017
1	GlucocorticoidsIBA 03/2017
1	VildagliptinIBA 07/2015
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 04/2012
1	Insulin AntibodiesIBA 04/2012

Therapy/Procedure

3	Therapeutics 10/2022 - 07/2015
2	Thyroidectomy 10/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 04/2021 - 03/2017
1	Gastrectomy 09/2021
1	Adjuvant Chemotherapy 04/2021
1	Length of Stay 02/2021
1	Glycemic Control 05/2018
1	Pancreaticoduodenectomy 05/2018
1	Immunotherapy 03/2017